Abstract

Following prolonged treatment (7 days) with diazepam (10 mg/kg/day, using ALZET mini-osmotic pumps) in rats, the function of adenosine receptors was assessed in specific structures of the brain, using both agonist ligand binding and adenylate cyclase assays. Binding to A 1 receptors was quantitified using [ 3 H]N 6-[( R)-1- methyl-2- phenylethyl] adenosine, a selective ligand at A 1 receptors. Differences in the binding of this ligand and that of [ 3 H]5'-N- ethylcarboxamide adenosine, which binds to both A 1 and A 2 subtypes of receptors with similar affinities, were used to quantify A 2 receptors. Treatment with diazepam failed to alter the binding of [ 3 H]-N 6-[( R)-1- methyl-2- phenylethyl] adenosine in all areas of the brain studied. However, the binding of A 2 receptors and A 2 receptor-mediated stimulation of adenylate-cyclase were significantly attenuated in striatal membranes from diazepam-treated rats. Thus, the present study indicated that functional adenosine A 2 receptors were desensitized after prolonged treatment with diazepam, since decreased agonist binding to A 2 receptors paralleled an attenuation in the stimulation by adenosine of the activity of adenylate cyclase, an effect mediated by the A 2 receptor. These results further indicate that the changes in adenosine A 2 receptors correlated with significant short-lasting alterations in the sleep-wake cycle during the withdrawal of diazepam. The alterations in sleep-wakefulness did not correlate with the effect of diazepam on benzodiazepine receptors since no changes were observed in the binding of benzodiazepine receptors.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call